<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T17:51:22Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/75197" metadataPrefix="mods">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/75197</identifier><datestamp>2025-03-03T20:01:13Z</datestamp><setSpec>com_10324_1181</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1387</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Bahillo Curieses, María del Pilar</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Fernández Velasco, Pablo</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Pérez López, Paloma</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Vidueira Martínez, Ana María</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Nieto de la Marca, María de la O</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Díaz Soto, Gonzalo</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2025-03-03T10:09:04Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2025-03-03T10:09:04Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2024</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Endocrine, 2024, vol. 86, n. 2, p. 539-545</mods:identifier>
<mods:identifier type="uri">https://uvadoc.uva.es/handle/10324/75197</mods:identifier>
<mods:identifier type="doi">10.1007/s12020-024-03881-6</mods:identifier>
<mods:identifier type="publicationfirstpage">539</mods:identifier>
<mods:identifier type="publicationissue">2</mods:identifier>
<mods:identifier type="publicationlastpage">545</mods:identifier>
<mods:identifier type="publicationtitle">Endocrine</mods:identifier>
<mods:identifier type="publicationvolume">86</mods:identifier>
<mods:identifier type="essn">1559-0100</mods:identifier>
<mods:abstract>Purpose To analyze the time in tight range (TITR), and its relationship with other glucometric parameters in patients with&#xd;
type 1 diabetes (T1D) treated with advanced hybrid closed-loop (AHCL) systems.&#xd;
Methods A prospective observational study was conducted on pediatric and adult patients with T1D undergoing treatment&#xd;
with AHCL systems for at least 3 months. Clinical variables and glucometric parameters before and after AHCL initiation&#xd;
were collected.&#xd;
Results A total of 117 patients were evaluated. Comparison of metabolic control after AHCL initiation showed significant&#xd;
improvements in HbA1c (6.9 ± 0.9 vs. 6.6 ± 0.5%, p &lt; 0.001), time in range (TIR) (68.2 ± 11.5 vs. 82.5 ± 6.9%, p &lt; 0.001),&#xd;
TITR (43.7 ± 10.8 vs. 57.3 ± 9.7%, p &lt; 0.001), glucose management indicator (GMI) (6.9 ± 0.4 vs. 6.6 ± 0.3%, p &lt; 0.001),&#xd;
time below range (TBR) 70–54 mg/dl (4.3 ± 4.5 vs. 2.0 ± 1.4%, p &lt; 0.001), and time above range (TAR) > 180 mg/dl&#xd;
(36.0 ± 7.6 vs. 15.1 ± 6.4%, p &lt; 0.001). Coefficient of variation (CV) also improved (36.3 ± 5.7 vs. 30.6 ± 3.7, p &lt; 0.001),&#xd;
while time between 140–180 mg/dl remained unchanged. In total, 76.3% achieved TITR > 50% (100% pediatric). Corre-&#xd;
lation analysis between TITR and TIR and GRI showed a strong positive correlation, modified by glycemic variability.&#xd;
Conclusions AHCL systems achieve significant improvements in metabolic control (TIR > 70% in 93.9% patients). The&#xd;
increase in TIR was not related to an increase in TIR 140–180 mg/dl. Despite being closely related to TIR, TITR allows for a&#xd;
more adequate discrimination of the achieved control level, especially in a population with good initial metabolic control.&#xd;
The correlation between TIR and TITR is directly influenced by the degree of glycemic variability.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">© 2024 The Author(s)</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
<mods:titleInfo>
<mods:title>Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>